
Vol. 69, No. 3, 2005
Free Abstract
Article (Fulltext)
Article (PDF 469 KB)
Laboratory/Clinical Translational Research
Association of Expression of Receptor for Advanced Glycation End Products and Invasive Activity of Oral Squamous Cell Carcinoma
Ujjal K. Bhawala, f, Yoshie Ozakib, Masahiro Nishimurab, Masaru Sugiyamac, Tomonori Sasahirah, Yuji Nomurad, Fuyuki Satoa, Katsumi Fujimotoa, Nobuyuki Sasakii, Masa-Aki Ikedag, Koichiro Tsujie, Hiroki Kuniyasuh, Yukio Katoa
Departments of aDental and Medical Biochemistry, bProsthetic Dentistry, cOral and Maxillofacial Surgery and dBiomaterials Science, Graduate School of Biomedical Sciences, Hiroshima University and eTwo Cells Co. Ltd., Hiroshima, fResearch and Development, Dentsply-Sankin KK and gSection of Molecular Embryology, Tokyo Medical and Dental University, Tokyo, hDepartment of Molecular Pathology, Nara Medical University, Kashihara, and iDepartment of Neuropsychiatry, Sapporo Medical University, Sapporo, Japan
Address of Corresponding Author
Oncology 2005;69:246-255 (DOI: 10.1159/000087910)
Key Words
- Receptor for advanced glycation end products
- Oral cancer
- Invasion
- Metastasis
Abstract
Objectives: The receptor for advanced glycation end products (RAGE) is a newly recognized factor regulating cancer cell invasion and metastasis. Nevertheless, the involvement of RAGE in the development and progression of oral squamous cell carcinomas has not been elucidated. This study investigated the expression of RAGE in ten oral squamous cell carcinoma cell lines including primary and metastatic cell lines and its association with invasion and metastasis. Methods: Reverse transcriptase-polymerase chain reaction, antisense phosphorothioate (S)-oligodeoxynucleotide assay, preparation of antibody, immunohistochemical staining, immunoblot analysis, migration assay, in vitro invasion assay, and wound-healing assay were used. Results: RAGE protein expression of metastatic cancer cells treated with RAGE antisense S-oligodeoxynucleotide was significantly reduced compared to that of sense S-oligodeoxynucleotide-treated cells. The migration assay showed that invasive activity was significantly reduced in metastatic cancer cells treated with RAGE antisense S-oligodeoxynucleotide. Similarly, during invasion assays, numbers of invading cells were also reduced with the addition of RAGE antisense S-oligodeoxynucleotide-treated cells. A wound-healing assay showed that only a few RAGE antisense S-oligodeoxynucleotide-treated cancer cells migrated into the scraped area, whereas sense S-oligodeoxynucleotide-treated cells showed many budding nests in the scraped area of the metastatic cell lines. Immunohistochemically, oral squamous cell carcinoma cells in the tumour mesenchymal border were often immunopositive, whereas basal cells in the normal mucosa were scarcely positive. Conclusions: These results suggest that RAGE expression appears to be closely associated with the invasiveness of oral squamous cell carcinoma and represents a promising candidate for assessing the future therapeutic potential in treating patients with oral carcinoma. Copyright © 2005 S. Karger AG, Basel
Author Contacts
Ujjal K. Bhawal Department of Dental and Medical Biochemistry Graduate School of Biomedical Sciences, Hiroshima University Kasumi 1-2-3, Minami-ku, Hiroshima 734-8553 (Japan) Tel. +81 82 257 5749, Fax +81 82 257 5749, E-Mail bhawal2002@yahoo.co.in
Article Information
Received: October 31, 2004
Accepted after revision: May 4, 2005
Published online: August 26, 2005
Number of Print Pages : 10
Number of Figures : 8, Number of Tables : 0, Number of References : 20 |
|

|

For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service. |
|
|